Korro Bio, Inc.
KRRO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $3 | $2 |
| % Growth | -25.3% | -42.7% | 12.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $1 | $3 | $2 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $14 | $21 | $20 | $17 |
| G&A Expenses | $7 | $7 | $8 | $8 |
| SG&A Expenses | $7 | $10 | $8 | $8 |
| Sales & Mktg Exp. | $0 | $3 | $0 | $0 |
| Other Operating Expenses | $0 | -$3 | $0 | $0 |
| Operating Expenses | $20 | $29 | $28 | $25 |
| Operating Income | -$19 | -$27 | -$25 | -$23 |
| % Margin | -1,764.9% | -1,863.2% | -981.2% | -1,014.5% |
| Other Income/Exp. Net | $1 | $1 | $2 | $2 |
| Pre-Tax Income | -$18 | -$26 | -$23 | -$21 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$18 | -$26 | -$23 | -$21 |
| % Margin | -1,657% | -1,765.1% | -917.1% | -933.5% |
| EPS | -1.92 | -2.74 | -2.49 | -2.26 |
| % Growth | 29.9% | -10% | -10.2% | – |
| EPS Diluted | -1.92 | -2.74 | -2.49 | -2.26 |
| Weighted Avg Shares Out | 9 | 9 | 9 | 9 |
| Weighted Avg Shares Out Dil | 9 | 9 | 9 | 9 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$17 | -$26 | -$24 | -$22 |
| % Margin | -1,548.8% | -1,779.1% | -933.1% | -959.4% |